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ABSTRACT Amyloid b-peptides (Ab) applied directly from solution tomodel lipid membranes produced dramatic changes in the
material properties of the bilayer when certain oxysterols were present in the bilayer. These effects were dependent on both lipid
and peptide composition, and occurred at peptide concentrations as low as 100 nM. Using micropipette manipulation of giant uni-
lamellar vesicles, we directly measured the lysis tension of lipid bilayers of various compositions. The glycerophospholipid
1-stearoyl-2-oleoyl-sn-glycero-3-phosphocholine (SOPC) constituted themain lipid component at 70mol%.The remaining 30mol%
was composed of the following pure or mixed sterols: cholesterol (CHOL), 7-ketocholesterol (KETO), or 7b-hydroxycholesterol
(OHCHOL). SOPC/CHOL bilayers did not exhibit signiﬁcant changes in mechanical properties after exposure to either Ab(1–42)
or Ab(1–40). Partial substitution of CHOL with KETO (5 mol %), however, caused a drastic reduction of the lysis tension after
exposure to Ab(1–42) but not to Ab(1–40). Partial substitution of CHOL with OHCHOL (5mol %) caused a drastic reduction of the
lysis tension after exposure to Ab(1–40) and to Ab(1–42). We attribute these effects to the reduction in intermolecular cohesive
interactions caused by the presence of the second dipole of oxysterols, which reduces the energetic barrier for Ab insertion into
the bilayer.
INTRODUCTION
The view of the role of amyloid b-peptide (Ab) in the etiology
of Alzheimer’s disease (AD) has undergone significant revi-
sion within the last two decades. Focus has shifted from the
neurotoxicity associated with the senile plaques composed of
aggregated Ab (the amyloid cascade hypothesis (1)) to the
activity of the peptide itself well before the onset of aggrega-
tion. Acting monomerically or in small oligomers (2), Ab has
been demonstrated to produce a wide range of effects on
model membranes and cells in culture (neuronal, PC12, neu-
roblastoma, and endothelial); however, no single pathological
mechanism has emerged. Indeed, it has become increasingly
clear that the neurotoxicity of Ab may derive from any of a
number of divergent yet concurrent pathways including the
following: 1), increased oxidative stress via the Ab-promoted
production of reactive oxygen species (3–7); 2), Ab-induced
stimulation of the inflammatory response (8,9); 3), membrane
depolarization resulting from the formation of structured cat-
ion-selective channels by membrane-spanning aggregates of
the peptide (10–14); 4), induction of necrosis (15) or apoptosis
(16,17); and 5), nonspecific membrane destabilization (18,19).
The insertion of a peptide into a lipid bilayer is coupled to the
work of creating a vacancy in the membrane; this work is de-
pendent on characteristics of the peptide and on the membrane
material properties (such as bilayer elasticity) that, in turn, are
dependent on the bilayer lipid composition (20). Experimental
evidence largely confirms a lipid composition dependence of
interactions between Ab and the lipid bilayer matrix of the cell
membrane, although the data are sometimes contradictory. For
example, electrostatic interactions between either Ab(1–40) or
Ab(1–42) and anionic lipid headgroups at acidic pH have been
reported to be the primary mediators of the initial interaction
between peptide and bilayer, with phosphatidylglycerol, cho-
lesterol (CHOL), and ganglioside all reported to mediate surface
binding of Ab (21–25). Kremer et al. (26,27), however, have
reported that specific electrostatic interactions are not required
for Ab-bilayer interactions, citing the indifference of steady-
state fluorescence anisotropy measurements on anionic, cat-
ionic, and zwitterionic headgroups. Their findings indicated
that, regardless of the surface charge of the target bilayer, the
transmembrane region of Ab(1–40) localized in the hydro-
phobic core and the peptide reduced membrane fluidity in a
manner that correlated with the degree of peptide aggregation
(26,27). These results suggest the importance of intrabilayer
interactions and membrane fluidity in influencing the activity of
Ab. In addition, Curtain et al. (28) reported that 20 mol % of
CHOL in mixed phosphatidylcholine and phosphatidylserine
bilayers appeared to inhibit peptide insertion.
As we will show in this article, we have demonstrated that
Ab applied directly to model lipid membranes produces
dramatic changes in the material properties of the bilayer
when certain oxysterols are present. These effects are de-
pendent on both lipid and peptide composition, and occur at
lower peptide concentrations (100 nM or less) than has pre-
viously been reported in the literature, to our knowledge.
MATERIALS AND METHODS
Lipids and peptides
The glycerophospholipid 1-stearoyl-2-oleoyl-sn-glycero-3-phosphocholine
(SOPC) and CHOL were purchased from Avanti Polar Lipids (Alabaster,
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AL) and used without further purification. We obtained 3b-hydroxy-5-
cholesten-7-one (7-ketocholesterol, KETO) and 5-cholestene-3b,7b-diol
(7b-hydroxycholesterol, OHCHOL) from Sigma-Aldrich (St. Louis, MO).
Phosphate buffered saline (PBS), its component salts (NaCl, KCl, KH2PO4,
and Na2HPO4), sucrose, and bovine serum albumin (BSA, essentially fatty
acid-free) also were from Sigma-Aldrich. The PBS was prepared according
to a standard preparation protocol (Current Protocols in Cell Biology (1998)
A.2A.5). Buffer pH and osmolarity were measured and adjusted to maintain
pH 7.4 and isoosmolarity with the vesicle suspensions (see below). All
solutions were filtered through 0.2-mm filters (Whatman, Florham Park, NJ)
to eliminate large particulate impurities. Two variants of Ab were obtained
from Calbiochem (San Diego, CA): Ab(1–42) (DAEFRHDSGYEVHH
QKLVFFAEDVGSNKGAIIGLMVGGVVIA) and Ab(1–40) (DAEFRH
DSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV). Peptides were
obtained as lyophilized powders and used without purification. Stock ali-
quots of peptide were prepared at 10 mM in ultrapure water (Milli-Q system;
Millipore, Billerica, MA) with a resistivity of 18 MV cm, frozen at 80C,
and thawed only once, immediately before each experiment.
The activity of Ab at the level of the cell membrane (both in vivo and in
vitro) has been widely reported to depend on the aggregation state of the
peptide (26,29,30). We therefore developed a formalism for the consistent
preparation and handling of stock solutions of Ab. Due to the potential
membrane perturbative effects of commonly used peptide solvents such as
dimethylsulfoxide, acetonitrile, hexafluoroisopropanol, and trifluoroacetic
acid, we chose to freeze Ab as stock aliquots in ultrapure water (18.2 MV cm
resistivity; Millipore) that were thawed, diluted in aqueous buffer, and used
immediately before each experiment. Peptide aggregation in stock prepara-
tions was assessed with a sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) Western blot assay using 4G8, which is a mouse
monoclonal antibody to Ab residues 17–24 (b amyloid (17–24) mAb Hu;
BioSource, Camarillo, CA) (31). Separation was conducted on Bis-Tris gel
(NuPAGE Novex Bis-Tris Gel; Invitrogen, Carlsbad, CA) according to the
manufacturer’s protocols. In this manner, we could monitor the degree of
aggregation of peptide samples and ensure that predominantly monomeric
forms were used in micropipette manipulation experiments. An example of
the results of this assay is shown in Fig. 1. Lane 1 consists of fresh Ab(1–42)
peptide that had been thawed immediately before SDS-PAGE; the sample
appears predominantly as a monomer (4.4 kDa), with some peptide ap-
pearing as dimer. In contrast to the fresh sample, lane 2 contains an aliquot of
Ab(1–42) that had been intentionally aggregated by incubation at room
temperature for 24 h before SDS-PAGE. As a result, multiple bands appear,
indicating the onset of peptide aggregation in various oligomeric states (di-
mers, trimers, and tetramers). It should be noted that the larger plaque-like
aggregates have yet to develop, as indicated by the absence of high molecular
weight bands at .30. All Ab samples used in the micromanipulation ex-
periments and subjected to this assay produced results similar to those shown
in lane 1. The SDS-PAGE Western blot test thus allowed us to confirm that
the aggregation state of Ab could be replicated for each experiment. To
minimize the extent of amyloid peptide aggregation, all solutions were
prepared immediately before each micromanipulation experiment, which
lasted no longer than 2 h.
Lipid and sterol compositions were confirmed by high-performance liquid
chromatography (HPLC), using an assay devised and described by Lang
(32). Lipid samples in methanol were eluted through a reversed-phase
octadecylsilane column with 100% HPLC-grade methanol at 1.0 mL/min.
Injection volumes were from 20 to 80 mL, and UV detection was at 207 nm.
Vesicle preparation
Giant unilamellar vesicles (GUVs) with an average diameter of 10–20 mm
were prepared by the electroformation method (33,34). Lipid mixtures in
organic solvent (chloroform or chloroform/methanol) were spread onto the
surface of platinum electrodes, and the solvent was removed in vacuo
overnight. The electrodes were then immersed in a cuvette containing 1 mL
aqueous sucrose solution (;200 mOsm). A 10-Hz alternating current electric
field was applied to the electrodes. The field amplitude was increased from
1.0 V to 2.0 V in 0.5 V increments every half hour. After 30 min at 2.0 V, the
frequency was lowered to 4 Hz for 30 min. After electroformation, giant
vesicles were harvested from the electroformation chamber by gentle aspi-
ration of the suspension with a pasteur pipette. GUVs were diluted and re-
suspended in equiosmotic PBS. The use of different solutions for the
hydrating and suspending media (aqueous sucrose and PBS, respectively)
provided two advantages. First, density differences drove vesicles to sink to
the bottom of the micromanipulation chamber, where they were then easily
located using contrast optics. Secondly, differences in the refractive indices
of the two solutions produced an enhanced optical contrast of the lipid vesicle
relative to its surroundings.
Micropipette manipulation
The micropipette manipulation technique has been described in detail else-
where (35,36). In brief, pipettes were fashioned from standard glass capillary
tubing, pulled to create a suitable taper using a commercially available pi-
pette puller (Sutter Instrument, Novato, CA), and then further trimmed with a
microforge (Narishige, Tokyo, Japan) to produce an open circular tip.
Pressure application and monitoring over five orders of magnitude (101–
104 Pa) were achieved by means of a custom-made, water-filled manometer
device with an inline pressure transducer (Validyne Engineering, Los
Angeles, CA) connected to the micropipettes by a flexible tubing system. The
micromanipulation stage was partitioned into two distinct slot chambers
(;400–500 mL total volume each) mounted side by side and parallel to each
other. The chambers were separated by a small air gap that allowed two
different chemical environments to be maintained simultaneously. One
chamber contained GUVs dispersed in PBS and served as a vesicle storage
reservoir. The other chamber constituted the test chamber and contained
equiosmotic PBS and Ab peptide at a known concentration. Both chamber
partitions were thermoregulated by a circulating water channel in the jacket
housing the chambers. Two micropipettes, mounted coaxially and opposite
to each other, were used in each experiment. A primary working pipette (4–6
mm internal diameter) was used to capture and mechanically manipulate
individual vesicles, and a transfer pipette (50–60 mm internal diameter) was
FIGURE 1 Results of SDS-PAGE Western blot assay of Ab(1–42)
aggregation. Lane 1 is freshly thawed Ab aliquot (10 mM in Milli-Q water;
Millipore); Lane 2 is Ab aliquot incubated at room temperature for 24 h.
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used as a protective sheath for the working pipette during the transfer of a
vesicle between the two chambers. The micromanipulation stage was mounted
onto the stage of an inverted microscope (Olympus IX51; Olympus, Melville,
NY) equipped with relief contrast (Hoffman modulation contrast) optics (403
objective, 0.6 NA, 40 mm working distance condenser).
Before the experiment, the chamber and the inner and outer surfaces of the
pipettes were incubated in 0.2 g % aqueous solution of BSA for 15–30 min to
eliminate the sticking of vesicles to the glass (37). The BSA solution was
then flushed out of the chamber several times with BSA-free PBS. Ab so-
lutions were prepared in PBS at appropriate concentrations (10 nM and 100
nM) and used to fill the second (test) chamber. All solution osmolarities were
measured in a freezing point osmometer (Advanced Instruments, Norwood,
MA) to monitor solute concentrations and ensure isoosmolarity.
In a typical experiment, an individual GUV resting at the floor of the
peptide-free storage chamber was selected and transferred into the test
chamber using the following protocol. The vesicle was aspirated at a sublytic
level of tension (typically 4–5 mN/m) by the working pipette, which—with
the captured vesicle—was then inserted inside the bore of the much larger
transfer pipette. Both pipettes were kept stationary while the micromanipu-
lation stage assembly was translated laterally on the microscope stage. In this
manner, the tips of the pipettes were translocated from one chamber envi-
ronment into the other. Upon emergence from the transfer pipette, the vesicle
was exposed to Ab peptide under continuous observation with video-
microscopy.
Elastic membrane deformations were studied by the application of me-
chanical tension to the giant vesicles by changing the suction pressure in the
working pipette using the manometer system (;20 Pa resolution). At any
given pressure, the bilayer tension t(t) followed from the relation in the
equation
tðtÞ ¼ PðtÞ3Dp=ð4ð1  Dp=DoÞÞ; (1)
whereP(t) is the instantaneous suction pressure applied to the vesicle at time t
by aspiration into the micropipette, Dp is the internal diameter of the pipette,
and Do is the diameter of the spherical portion of the vesicle outside the
pipette (Fig. 2) (38,39). For small deformations, changes in the parameter Do
are beyond the limits of resolution, and so Do is treated as a constant for each
vesicle. Under this constraint, a fluid, elastic bilayer membrane that forms a
closed vesicle at constant volume experiences relative surface area changes
as the bilayer tension is changed (for example, by lifting or lowering the
water reservoir in the manometer). Changes in membrane area induced by
pipette aspiration are described by the relation in the equation
DA ¼ pDpð1  Dp=DoÞ3DL: (2)
Under this approximation, changes in membrane area are directly propor-
tional to changes in the length (DL) of the portion of the membrane aspirated
inside the micropipette. A plot of tension versus relative area change (DA
divided by initial area Ao) directly provides the elastic area expansion
modulus of the lipid bilayer from the slope of the linear fit. The critical lysis
tension tc is defined as the maximal tension withstood by the bilayer before
failure. Recently, Evans and co-workers (40) demonstrated that the critical
lysis tension of lipid bilayers is not solely a function of the bilayer
composition. Instead, the critical lysis tension also depends dynamically
on the tension loading rate in the bilayer. In this article, our goal was not to
map the entire dynamic tension spectrum for each membrane composition
but to make a qualitative comparison of the cohesive strengths of bilayers
after exposure to Ab peptide as a function of oxysterol content. We therefore
chose to focus on a single loading rate applied to all compositions in the
experiment. Using an experimental arrangement identical to that of Evans
and co-workers (40), we performed an infusion-withdrawal syringe pump-
driven pressure manometer (VWR International, West Chester, PA) to
consistently apply tension to the bilayer at a constant ramp on the order of
1 mN m1 s1, making adjustments to compensate for slight variations in
vesicle and pipette size. A sample tension loading ramp is shown in Fig. 2.
Data were analyzed using image analysis software (Scion Image 4.0;
Scion, Frederick, MD) for measurement of vesicle geometric parameters
directly from videomicrographic recording of the experiment (obtained using
digital video editing software (iMovie; Apple, Cupertino, CA) on a personal
computer (PowerPC G4; Apple)). All relevant experimental quantities (in-
cluding time, pipette pressure, solution osmolarities, and temperature) were
recorded. Bilayer material properties were calculated and studied using
analysis and graphing software (Origin 7.0; OriginLab, Northampton, MA).
Statistical significance of data relative to controls was determined by
Student’s t-test. Comprehensive treatment of the membrane mechanics used
in the micropipette manipulation technique can be found in a monograph by
Evans and Skalak (41) and several more recent reviews (35,36,42).
RESULTS
HPLC of pure lipid stocks showed the elution of well-
resolved symmetrical peaks (Fig. 3 A). The chromatogram
for OHCHOL reveals a secondary peak eluting at;1.77 min,
at the same point at which KETO elutes, which probably
reflects the presence of impurities in the stock. Chromato-
grams of lipid samples that nominally consisted of SOPC/
CHOL (7:3 mol) and were subjected to autooxidation in air
revealed the presence of additional components (Fig. 3 B,
bottom trace). The autooxidized sample was ‘‘spiked’’ in turn
by pure KETO and then pure OHCHOL, resulting in ampli-
fication of the corresponding peaks on the chromatogram
FIGURE 2 (A) Videomicrograph of a typical GUV, partially aspirated by
a micropipette and viewed under Hoffman modulation contrast optics. The
scale bar is 5 mm. (B) A sample tension loading ramp. Tension was steadily
increased at the rate of ;1 mN/m/s.
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(Fig. 3 B, middle and top traces). These results indicate the
conversion of some CHOL into its major oxidation products,
KETO and OHCHOL, consistent with the known oxidative
paths of CHOL (43,44). HPLC revealed the presence of these
oxysterols as distinct peaks that were well-resolved from
SOPC and CHOL; these results are in agreement with those
obtained by Lang (32).
GUVs were prepared for the following four compositions:
1), SOPC; 2), SOPC/CHOL (70:30 mol); 3), SOPC/CHOL/
KETO (70:25:5 mol); and 4), SOPC/CHOL/OHCHOL
(70:25:5 mol). Furthermore, GUVs were prepared from
SOPC/CHOL (70:30 mol) stock that was subjected to auto-
oxidation in air for 48 h. GUVs of all lipid compositions
tested in this experiment were stable on the timescale of the
experiment (typically 2 h). GUV samples that were stored at
room temperature overnight and retested the next day showed
no significant changes in mechanical properties. As a control,
we transferred individual GUVs of each composition from a
chamber containing PBS into a second chamber containing
PBS. No change in either area expansion modulus or lysis
tension was observed after such a transfer. Also, GUVs did
not exhibit any gross morphological changes as a conse-
quence of the transfer, such as surface invaginations or
vesiculation. We also performed control measurements of
GUVs that were not transferred, and we found the mechan-
ical properties to be consistent with values reported in the
literature in the case of pure SOPC and SOPC/CHOL.
In the micromanipulation transfer experiment, individual
GUVs were transferred into a chamber containing peptide at
a concentration of 100 nM. The peptide/lipid ratio (P/L) was
roughly estimated based on the bulk peptide concentration,
the volume of the micromanipulation chamber, and the ge-
ometry of the vesicle. The number of lipids in the GUV was
calculated from the diameter and known lipid dimensions,
ignoring the presence of ‘‘hidden’’ surface area in the form of
surface ruffles below the optically detectible limit. A con-
servative estimate placed P/L on the order of 104, well above
the P/L values reported in other studies (22,24). In the mi-
cromanipulation transfer experiment, the GUV bilayer,
therefore, is exposed to an excess of peptide relative to lipid.
Pure SOPC bilayers appeared to be unaffected by exposure
to either Ab(1–42) or Ab(1–40). SOPC GUVs subjected to
mechanical tension exhibited elastic area expansion with a
corresponding apparent compressibility modulus consistent
with values reported in the literature (;200 mN/m) (45). The
same GUV, after transfer to the chamber containing 100 nM
Ab(1–42), showed the same elastic deformation response
to aspiration-induced stress. Lysis tension values of pure
SOPC bilayers were unchanged by exposure to Ab (Fig. 4).
This finding is consistent with previous studies that indicated
a lack of interaction between Ab and zwitterionic mem-
branes.
FIGURE 3 HPLC chromatograms of various (A) pure
and (B) mixed lipid systems. All samples were in MeOH
and eluted at 1.0 mL/min. UV detection was at 207 nm. (B)
The chromatogram at the bottom was obtained for a sample
of SOPC/CHOL (7:3 mol) autooxidized in air. The middle
chromatogram was obtained for the same SOPC/CHOL
sample, with the addition of pure KETO. The top chromato-
gram was obtained for the KETO-spiked sample, with the
addition of pure OHCHOL.
FIGURE 4 Lysis tension values of SOPC GUVs, with and without
exposure to either 100 nM Ab(1–42) or 100 nM Ab(1–40). Values are
mean 6 SD (N ¼ 20).
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SOPC bilayers containing CHOL and oxysterols (KETO or
OHCHOL) were tested in the same manner as pure SOPC bi-
layers. Lysis tension values for SOPC/CHOL were in agreement
with literature values (;12.6 6 3.0 mN/m) (Fig. 5), whereas
SOPC/CHOL/KETO was indistinguishable from SOPC/CHOL
(12.3 6 1.8 mN/m) (Fig. 6) and SOPC/CHOL/OHCHOL was
lower than SOPC/CHOL (8.6 6 1.9 mN/m) (Fig. 7).
Bilayers containing sterols and oxysterols exhibited dif-
ferent responses to Ab peptides depending on the length of
the individual peptide. As with pure SOPC bilayers, the
mechanical properties of SOPC/CHOL bilayers did not
change after exposure to either Ab(1–42) or Ab(1–40). How-
ever, partial substitution of CHOL with KETO (5 mol %)
caused a drastic reduction of the lysis tension (2.03 6
0.07 mN/m), under an identical tension loading rate, after
exposure to Ab(1–42) (Fig. 6). In contrast, Ab(1–40) ex-
posure resulted in only a modest decrease in lysis tension
(10.8 6 0.7 mN/m). This difference, though, was not statis-
tically significant. Partial substitution of CHOL with OHCHOL
(5 mol %) caused a drastic reduction of the lysis tension after
exposure to Ab(1–40) (2.056 0.31 mN/m) and to Ab(1–42)
(2.85 6 0.43 mN/m) (Fig. 7).
Finally, lipid mixtures nominally consisting of SOPC/
CHOL (70:30 mol) that were autooxidized in air were hy-
drated and reconstituted into GUVs. These vesicles demon-
strated lower thresholds for lysis (7.45 6 2.97 mN/m) than
SOPC/CHOL GUVs, and a further marked decrease in lysis
tension after exposure to Ab(1–42) (0.69 mN/m) but not to
Ab(1–40) (Fig. 8). These vesicles were also observed to lose
optical contrast over time, as shown in Fig. 9. The initial
contrast was due to the difference in optical densities of the
sucrose solution entrapped inside the vesicle and the PBS
outside the vesicle. After exposure to Ab(1–42), with the
vesicles held under very low suction pressure (applied ten-
sion on the order of 0.5 mN/m), the contrast weakened rap-
idly, on a timescale of 1 min, indicating a relatively rapid
mixing of internal and external solutes through a per-
meabilized membrane. Throughout this process, the cohesion
of the lipid bilayer itself was maintained, and the bilayer
remained faintly visible under Hoffman modulation contrast
optics. After the contrast difference was completely lost, the
bilayer itself was extremely fragile, failing at low levels of
applied tension (0.7–2.8 mN/m).
DISCUSSION
Aging is accompanied by compositional changes in brain
membranes; for example, transbilayer CHOL distributions
tend to equalize with age by mechanisms not fully under-
stood (dysfunction in apolipoprotein E and/or sterol carrier
protein-2 have been proposed) (46). Such changes impact a
host of interrelated membrane properties including bilayer
fluidity, domain structure, and permeability that, in turn,
FIGURE 5 Lysis tension values of SOPC/CHOL (7:3 mol) GUVs, with
and without exposure to either 100 nM Ab(1–42) or 100 nM Ab(1–40).
Values are mean 6 SD (N ¼ 13).
FIGURE 6 Lysis tension values of SOPC/CHOL/KETO (70:25:5 mol)
GUVs, with and without exposure to either 100 nM Ab(1–42) or 100 nM
Ab(1–40). Values are mean6 SD (N ¼ 12). Statistical significance relative
to controls was determined by Student’s t-test (*p , 0.005).
FIGURE 7 Lysis tension values of SOPC/CHOL/OHCHOL (70:25:5
mol) GUVs, with and without exposure to either 100 nM Ab(1–42) or
100 nM Ab(1–40). Values are mean 6 SD (N ¼ 7). Statistical significance
relative to controls was determined by Student’s t-test (*p , 0.01; **p ,
0.005).
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directly affect cell function and viability. We focused on the
role of oxysterols on the mechanical stability of lipid bilayers
in the model membrane system of the giant bilayer vesicle
because of the relative enrichment of CHOL in brain mem-
branes (47,48), and because Ab has been directly implicated
in oxidative stress damage in the brain (4,49). The GUV
comprises the simplest model of the cell membrane that re-
tains the basic bilayer structure of the membrane on a size
scale comparable to cells (tens to hundreds of microns).
SOPC was selected as the major phospholipid component
because it is readily reconstituted as GUVs, the mechanical
properties of which have been thoroughly characterized by
micropipette manipulation techniques (45,50–52). The SOPC
bilayer vesicle, therefore, constitutes a useful benchmark for
comparisons with GUVs of other lipid compositions. We
chose two of the most commonly occurring oxysterol deriv-
atives of CHOL, KETO and OHCHOL (43,44); these com-
pounds have been reported to be cytotoxic (characterized
by phosphatidylserine externalization, loss of mitochondrial
transmembrane potential, increased membrane permeability
to propidium iodide, and membrane fragmentation) (53). The
composition of the various lipid bilayers used in the micro-
manipulation experiments was assayed by HPLC, SOPC,
CHOL, KETO, and OHCHOL and exhibited distinctive peaks
on chromatograms and so enabled clear identification of
each. Furthermore, the chromatographic ‘‘fingerprint’’ of each
component was used to identify the components of autooxi-
dized lipid samples.
In the micropipette manipulation experiments, we first
established the baseline properties of the reference bilayers.
The apparent elastic area expansion modulus and the lysis
tension (at 1 mN/m/s loading rate) of pure SOPC and SOPC/
CHOL (7:3 mol) bilayers were in agreement with values
reported in the literature (42,45). The mechanical properties
of these bilayers were unchanged by transfer of the GUVs
from one chamber to another if the same buffer was present in
both chambers. Furthermore, the mechanical properties were
unaffected by exposure of the bilayer to 100 nM Ab(1–42) or
100 nM Ab(1–40). These results are consistent with previous
findings that suggested that a negative bilayer surface charge
was a requisite for peptide interaction with the bilayer and
that Ab peptides did not perturb zwitterionic membranes
(22). In addition to surface charge–mediated interactions,
CHOL has been shown to condense bilayer molecular area
through attractive van der Waals interactions between
phospholipid acyl moieties and the sterol ring structure. This
cohesivity increases the energetic barrier against insertion of
Ab peptides into the bilayer structure. As shown by Zhelev
FIGURE 8 Lysis tension values of autooxidized SOPC/CHOL (nominal
composition 7:3 mol) GUVs, with and without exposure to either 100 nM Ab(1–
42) or 100 nM Ab(1–40). Values are mean 6 SD (N ¼ 4). Statistical signif-
icance relative to controls was determined by Student’s t-test (*p , 0.005).
FIGURE 9 Videomicrograph of a GUV composed of autooxidized
SOPC/CHOL (7:3 mol), viewed under Hoffman modulation contrast optics.
The vesicle was held under very low suction pressure (applied tension on the
order of 0.5 mN/m) below the aspiration threshold. 100 nM Ab(1–42)
caused the GUV to become leaky, as indicated by the loss of optical contrast
between the sucrose solution inside the vesicle and the PBS outside the
vesicle. (Top panel) time ¼ 0; (middle panel) 33 s elapsed; and (bottom
panel) 1 min elapsed.
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et al. (20), the work for creating a vacancy for insertion of a
peptide into a bilayer is proportional to the bilayer area ex-
pansion modulus.
In contrast to the behavior and properties of CHOL-con-
taining bilayers exposed to Ab peptides, lysis tensions of
oxysterol-containing bilayers reflected dramatic destabiliza-
tion by Ab peptides in a composition-dependent manner.
SOPC/CHOL/KETO (70:25:5 mol) bilayers did not display a
significant change in lysis tension relative to SOPC/CHOL;
after exposure to 100 nM Ab(1–42), however, a striking
decrease in lysis tension was observed. Under these condi-
tions, the GUVs were extremely fragile, collapsing under
very low levels of applied stress. Exposure to Ab(1–40),
however, did not diminish the lysis tension of KETO-
containing membranes. In comparison, the lysis tensions of
SOPC/CHOL/OHCHOL (70:25:5 mol) bilayers were lower
than those of SOPC/CHOL bilayers, showing an ;32 per-
cent reduction. In addition to this effect, both Ab(1–42) and
Ab(1–40) further reduced the lysis tension of the OHCHOL-
containing bilayers, resulting in their failure under very low
applied mechanical stress.
The introduction of an additional dipole to the CHOL
ring—e.g., a ketone or hydroxyl group—has important
ramifications for bilayer structure that may explain the ob-
served changes in bilayer mechanical properties on addition
of Ab peptides. The single hydroxyl moiety of CHOL an-
chors the molecule to the bilayer in a configuration in which
the plane of the sterol ring is perpendicular to the bilayer
surface. This configuration enables the sterol to locally order
the acyl chains of neighboring lipid molecules, particularly at
the carbons most proximal to the glycerol backbone. This
effect strengthens intrabilayer cohesive interactions and in-
creases the energetic barrier to peptide insertion into the bi-
layer. In comparison, the introduction of a second dipole at
the C7 position of the oxysterols used in this study imparts a
tilt to the molecule with respect to the bilayer surface, as the
dipole seeks exposure to water (54,55). The result is a slight
thinning of the bilayer (although this may be partially offset
by an increase in the hydration layer of the bilayer), as the
free volume is increased within the bilayer, especially at the
midplane (56). The increased disorder within the bilayer is
reflected in a reduced cohesion in the oxysterol-containing bi-
layer relative to the CHOL-containing bilayer (57). Simon and
co-workers demonstrated that substitution of 6-ketocholestanol
(an oxysterol similar to KETO) for CHOL in 1:1 SOPC/
CHOL bilayers results in a.50% reduction in the elastic area
expansion modulus (54), indicating that such oxysterol-
containing bilayers are more easily expanded under isotropic
tension than their CHOL-containing counterparts. The re-
duction in intermolecular cohesive interactions reduces the
energetic barrier for Ab insertion into the bilayer. The hy-
drophobic effect then drives the insertion of the peptide into
the bilayer, even in the absence of surface electrostatic in-
teractions to mediate lipid-peptide attraction. This model is
consistent with the results of Kremer et al. (26,27).
The effect of Ab peptides on the mechanical stability of
oxysterol bilayers is consistent with the model of bilayer
strength recently described by Evans and co-workers (40). In
this model, the rupture of fluid lipid bilayers is described as a
two-regime kinetic process that is dependent on the loading
rate of tension in the bilayer, with the cutoff between the
regimes occurring on the order of 10 mN/m/s. At slow
loading rates (including the rate applied in our experiments),
the rupture strength is predicted by the classic cavitation
model of opening and expanding an unstable hole or pore in
the bilayer within the lifetime of the hole. In the case of slow
loading rates, membrane edge energy governs the failure
tension and can be reduced by the introduction of defects,
such as small molecules, to the bilayer. This outcome has been
suggested as an explanation, in part, for the membrane effects
of small molecules such as salicylate (58) and amphiphilic
antimicrobial peptides (59). The propensity of the Ab peptide
to insert itself into the bilayer is driven by the hydrophobic
effect, with the transmembrane residues (28–40 or 28–42)
adopting an alpha-helical conformation that provides internal
hydrogen bonding of the peptide necessary to accommodate
the C¼O and NH groups within the hydrocarbon core of the
bilayer (60). Simulations of Ab peptide structure based on
NMR spectroscopy data indicate that the transmembrane
portion of the peptide is approximately the same size as the
thickness of the typical lipid monolayer (61) and that the
overall structure of the peptide is similar to that of the he-
magglutinin peptide fusion domain (62). These results sug-
gest that Ab localization is keyed to the thickness of the target
membrane. Therefore, it is possible that the addition of KETO
induces the membrane thinning that accommodates Ab(1–42)
insertion, whereas OHCHOL-induced thinning makes possi-
ble the insertion of both Ab(1–42) and Ab(1–40). The con-
version of CHOL to oxysterols and the accompanying effects
on AD membrane stability may explain results reported by
Mason et al. (63) that indicate the concurrence of CHOL
deficits and membrane thinning in AD cortical membranes.
As demonstrated in this study, the addition of oxysterols to
simple PC-CHOL lipid membranes alters the membrane
mechanical properties and causes the bilayer to be further
destabilized by the exogenous addition of Ab peptides. In the
latter event, the peptides act as point defects from which
membrane rupture proceeds at lower levels of applied ten-
sion. Furthermore, oxysterols may increase plasma mem-
brane permeability, leading to membrane depolarization.
Geddes et al. (64) have demonstrated that mechanical de-
formation of cultured neurons that simulate physiological
stress distributions in the brain results in a transient increase
in plasma membrane permeability, which is due to the im-
position of membrane tears. Therefore, it is reasonable to
expect that structurally destabilizing changes in neuronal
membrane composition should increase the cellular damage
inflicted by mechanical insults to the brain. It has been re-
ported that Ab itself promotes the formation of oxysterols and
other lipid peroxidation products that are, in effect, catalyzing
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conditions under which peptide-induced destabilization may
occur (65,66). These results are consistent with studies re-
ported by Svennerholm and Gottfries (67) that demonstrate
synaptic membrane loss as a hallmark of type 1 AD. There-
fore, one of the many pathways by which Ab leads to neu-
rodegeneration may involve compositional changes in the
synaptic plasma membrane, coupled with the local accumu-
lation of membrane-active peptide, that render the bilayer
vulnerable to damage at even low levels of mechanical stress
to the brain. Investigating how Ab peptides alter the prop-
erties of the bilayer, and how the interactions depend spe-
cifically on individual bilayer constituents of biological
relevance, will further the general understanding of all dis-
eases involving abnormal protein-cell interactions.
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